A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer
2022 · Nature Communications · 51 citations
https://doi.org/10.1038/s41467-022-34838-w
G
Guanglei Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
173
Papers
2.4K
Citations
29
h-index
67
i10-index
Guanglei Chen is an academic researcher from Jiangsu Normal University. The author has contributed to research in topics: Breast Cancer Treatment Studies & Advanced Breast Cancer Therapies & Soil and Water Nutrient Dynamics. The author has an h-index of 29, co-authored 148 publications.
ORCID: 0000-0002-8107-628XPapers by this author
worksCMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer
2023 · Molecular Cancer · 47 citations
https://doi.org/10.1186/s12943-023-01716-y
Unraveling the Role of Metal Vacancy Sites and Doped Nitrogen in Enhancing Pseudocapacitance Performance of Defective MXene
2023 · Small · 44 citations
https://doi.org/10.1002/smll.202307408
Unraveling the Ionic Storage Mechanism of Flexible Nitrogen‐Doped MXene Films for High‐Performance Aqueous Hybrid Supercapacitors
2024 · Small · 41 citations
https://doi.org/10.1002/smll.202405817
Establishment and Verification of a Bagged-Trees-Based Model for Prediction of Sentinel Lymph Node Metastasis for Early Breast Cancer Patients
2019 · Frontiers in Oncology · 27 citations
https://doi.org/10.3389/fonc.2019.00282
Characteristics and survival in bone metastatic breast cancer patients with different hormone receptor status: A population-based cohort study
2022 · Frontiers in Oncology · 20 citations
https://doi.org/10.3389/fonc.2022.977226
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat